What about know-how: heightened obviousness and lowered disclosure is not a panacea to the American patent system for biotechnology medication and pharmaceutical inventions in the post-KSR era.

This document cites

• Federal Cases - 758 F.2d 594 (Fed. Cir. 1985), 84-699, Patlex Corp. v. Mossinghoff
• Federal Cases - 853 F.2d 894 (Fed. Cir. 1988), 87-1486, In re O'Farrell
• Federal Cases - 874 F.2d 804 (Fed. Cir. 1989), 88-1513, Merck & Co., Inc. v. Biocraft Laboratories, Inc.
• Federal Cases - 927 F.2d 1200 (Fed. Cir. 1991), 90-1273, Amgen, Inc. v. Chugai Pharmaceutical Co., Ltd.
• Federal Cases - 991 F.2d 781 (Fed. Cir. 1993), 92-1375, In re Bell



See all quotations

• Federal Cases - 424 F.3d 1293 (Fed. Cir. 2005), 05-1043, Cross Medical Products, Inc. v. Medtronic Sofamor Danek, Inc.
• Federal Cases - 464 F.3d 1286 (Fed. Cir. 2006), 06-1019, Alza Corp. v. Mylan Laboratories, Inc.
• Federal Cases - 492 F.3d 1350 (Fed. Cir. 2007), 06-1329, Takeda Chemical Industries, Ltd. v. Alphapharm Pty., Ltd.
• Federal Cases - 51 F.3d 1552 (Fed. Cir. 1995), 94-1202, In re Deuel
• Federal Cases - 520 F.3d 1358 (Fed. Cir. 2008), 2007-1223, Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories, Inc.
• Federal Cases - 533 F.3d 1353 (Fed. Cir. 2008), 2007-1397, Eisai Co. Ltd. v. Dr. Reddy's Laboratories, Ltd.
• Federal Cases - 544 F.3d 1341 (Fed. Cir. 2008), 2007-1300, Abbott Laboratories v. Sandoz, Inc.
• Federal Cases - 561 F.3d 1351 (Fed. Cir. 2009), 2008-1184, In re Kubin
• Federal Cases - 527 U.S. 627 (1999), 98-531, Florida Prepaid Postsecondary Ed. Expense Bd. v. College Savings Bank
• Federal Cases - 525 U.S. 55 (1998), 97-1130, Pfaff v. Wells Electronics
• Federal Cases - 535 U.S. 826 (2002), 01-408, Holmes Group, Inc. v. Vornado Air Circulation Systems, Inc.
• Federal Cases - 537 U.S. 186 (2003), 01-618, Eldred v. Ashcroft
• Federal Cases - 550 U.S. 398 (2007), 04-1350, KSR International Co. v. Teleflex Inc.
• Federal Cases - 383 U.S. 1 (1966), 11, Graham v. John Deere Co. of Kansas City